-
Eisai Releases Corporate Film “1 Percent, 1 Mission. Change the World.”
-
Video for World Cancer Day 2025
-
New Video on Eisai's Activities for Lymphatic Filariasis Elimination
World Neglected Tropical Diseases Day
-
Human Capital Report 2024
-
Value Creation Report 2024
-
World Alzheimer’s Month ー Life Goes On 2024
A documentary video portraying the daily life of people living with dementia (in Japanese)
-
April 29, 2025
-
April 16, 2025
-
April 14, 2025
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission
-
April 1, 2025
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission
-
March 28, 2025
“New Answers to Dementia”
Eisai Launches Corporate Awareness Campaign
-
April 24, 2025
-
April 7, 2025
IR "Renewal of Investor Relations section launched on corporate website"
-
March 27, 2025
-
March 25, 2025
-
March 6, 2025
-
February 19, 2025
Eisai’s Corporate Pension Fund Announces Adoption of “Asset Owner Principles”
-
October 3, 2024
EISAI NAMED AS ONE OF NEWSWEEK’S WORLD’S MOST TRUSTWORTHY COMPANIES 2024
-
June 21, 2024
Notification Regarding Revision of “Eisai Global Code of Conduct for Business Partners”
-
June 3, 2024
The Naito Museum of Pharmaceutical Science and Industry Listed as “Registered Museum”
-
April 8, 2024
Sustainability
32 countries 2.51billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of December 2024)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries
